Aude Mallavialle

Jan 21, 2025 | bpspubs.onlinelibrary.wiley.com | Timothée David |ICM Montpellier France |Aude Mallavialle |Valérie Laurent-Matha

CONFLICT OF INTEREST STATEMENT No potential conflicts of interest were disclosed by all authors. Supporting Information Filename Description bph17437-sup-0001-Supporting_Information.pdfPDF document, 1.5 MB Figure S1. Immunotherapy of TNBC with the F1 anti-cathepsin-D antibody. Figure S2. Immunotherapy with anti-cathepsin-D antibodies triggers both innate and adaptive antitumour immunity in an immunocompetent mouse model of triple-negative breast cancer (TNBC). Figure S3.

Nov 29, 2023 | bpspubs.onlinelibrary.wiley.com | Timothée David |Univ Montpellier |Aude Mallavialle |ICM Montpellier France

Supporting Information Filename Description bph16291-sup-0001-supplemental.pdfPDF document, 794.5 KB Data S1. Supporting Information bph16291-sup-0002-sup marked.docxWord 2007 document , 35.7 KB Figure S1. CathD expression and secretion in the 4T1 murine TNBC cell line. Whole cell extracts (lysate, 20 μg proteins) and 24-hour conditioned media (SN, 40 μl) were separated by 13.5% SDS-PAGE and immunoblotted with an anti-mouse CathD antibody (#AF1029).